₹-20.10
(Market cap
₹13,809 Cr
Recently Viewed
Clear AllMarket cap
₹13,809 Cr
Revenue (TTM)
₹1,284 Cr
P/E Ratio
102.8
P/B Ratio
11.3
Div. Yield
0 %
Value Research Rating
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹134 Cr
ROE
30.7 %
ROCE
27 %
Industry P/E
43.86
EV/EBITDA
52.9
Debt to Equity
0.8
Book Value
₹33.4
EPS
₹8.7
Face value
1
Shares outstanding
165,092,124
CFO
₹202.28 Cr
EBITDA
₹616.85 Cr
Net Profit
₹242.23 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Rubicon Research
| 22.8 | 8.5 | 28.5 | -- | -- | -- | -- |
|
BSE Healthcare
| -1.9 | -1.8 | -2.4 | 7.7 | 24.3 | 13.4 | 10.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Rubicon Research
|
836.1 | 13,809.1 | 1,284.3 | 134.4 | -- | 30.7 | 102.8 | 11.3 |
| 2,362.2 | 19,351.5 | 1,215.1 | 284.8 | 28.7 | 21.1 | 67.4 | 12.7 | |
| 724.2 | 14,230.2 | 7,266.8 | 627.5 | 11.9 | 12.6 | 22.6 | 2.6 | |
| 377.9 | 14,466.8 | 2,051.5 | 180.5 | 11.6 | 7.7 | 71.7 | 3.8 | |
| 632.0 | 15,658.3 | 5,092.5 | 545.5 | 15.9 | 14.1 | 28.7 | 3.5 | |
| 1,104.2 | 19,771.9 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 12.7 | 2.2 | |
| 1,438.9 | 16,477.6 | 1,419.3 | 20.1 | 8.4 | 0.5 | 819.7 | 2.8 | |
| 146.0 | 19,420.3 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.4 | |
| 404.7 | 16,309.0 | 3,720.2 | 352.1 | 13.7 | 8.2 | 46.3 | 3.4 | |
| 1,343.8 | 21,839.8 | 3,151.0 | -10.0 | 8.4 | 2.5 | 992.7 | 4.7 |
No Review & Analysis are available.
--
Incorporated
1999
Chairman
--
Managing Director
Pratibha Sudhir Pilgaonkar
Headquarters
Thane, Maharashtra
Website
Looking for more details about Rubicon Research Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Announcements
View Announcements
The share price of Rubicon Research Ltd is ₹836.10 (NSE) and ₹836.45 (BSE) as of 10-Apr-2026 IST. Rubicon Research Ltd has given a return of --% in the last 1 years.
The P/E ratio of Rubicon Research Ltd is 102.78 times as on 10-Apr-2026, a 134 premium to its peers’ median range of 43.86 times.
The P/B ratio of Rubicon Research Ltd is 11.32 times as on 10-Apr-2026, a 230 premium to its peers’ median range of 3.43 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Rubicon Research Ltd are Rs 885.80 and Rs 570.75 as of 12-Apr-2026.
Rubicon Research Ltd has a market capitalisation of ₹ 13,809 Cr as on 10-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Rubicon Research Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.